From insiders leaving to the CEO of the company resigning, Liberty Health Sciences (CSE:LHS) (OTCQX:LHSIF) has had a difficult start to 2019. But it’s almost the end of March now, and Liberty Health Sciences is starting to see some positives.
For instance, just yesterday, March 25th, Liberty Health said it received approval to dispense flower products to patients in Florida. This is significant news, for more reasons than one.
Liberty Health Sciences Dispensing Flower Products in Florida
As mentioned, receiving the green light from the Florida Department of Health is significant for several reasons. At first glance, however, there are two obvious ones.
Because of the approval, Liberty Health Sciences is now one of the first companies to provide smokeable marijuana products to patients in the southeasternmost US state.
Addressing the news, interim CEO Victor Mancebo said “this is truly a historic moment” for the company. He also said it is one for the state as well, as “patients in Florida have been eager for this bill to pass as there is a fundamental need for this medicine in all of its forms.”
The past few months have been crazy for Liberty Health Sciences, but the company appears to be turning things around. Yesterday’s announcement proves that, and it seems cannabis investors recognize this. After all, LHS stock is looking good, trading in the green today. Same goes for the LHSIF stock, which trades on the OTCQX Marketplace, and closed yesterday up nearly 3%.
According to Yahoo Finance, at market close, LHS stock was up 1.05%. The trading price was $0.96.
There are several companies to watch in the cannabis market right now, and it could be argued that Liberty Health is one of them.
What do you think? Let us know in the comments below.
Featured image: Canva